Agenus Inc. (AGEN)
| Previous close | 5.40 |
| Open | 5.36 |
| Bid | 5.61 x 1200 |
| Ask | 5.75 x 300 |
| Day's range | 5.22 - 6.14 |
| 52-week range | 5.22 - 42.60 |
| Volume | |
| Avg. volume | 600,173 |
| Market cap | 119.392M |
| Beta (5Y monthly) | 1.28 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -13.80 |
| Earnings date | 07 May 2024 - 13 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 88.75 |
- Business Wire
Agenus Announces Updated Phase 1 Data and Progress on BOT/BAL Development in Metastatic MSS Colorectal Cancer
LEXINGTON, Mass., April 12, 2024--Agenus Inc. (NASDAQ: AGEN), a leader in discovering and developing novel immunological agents to treat various cancers, today announced updated results from its Phase 1 clinical trial of BOT/BAL combination therapy in patients with metastatic CRC that is not microsatellite instability-high (MSS) or deficient mismatch repair (dMMR). These findings build upon the compelling clinical activity demonstrated by BOT/BAL across nine different cancer types in Agenus' bro
- Business Wire
Agenus Announces Reverse Stock Split of Common Stock
LEXINGTON, Mass., April 05, 2024--Agenus Inc. (Nasdaq: AGEN), a leader in discovering and developing novel immunological agents to treat various cancers, today announced its stockholders have approved a one-for-twenty reverse stock split of its issued and outstanding common stock, which will go into effect at 12:01 a.m., Eastern Time on April 12, 2024. The reverse stock split is intended to give Agenus greater flexibility in its future financing needs and to increase the per share trading price
Simply Wall St.US$5.50: That's What Analysts Think Agenus Inc. (NASDAQ:AGEN) Is Worth After Its Latest Results
There's been a notable change in appetite for Agenus Inc. ( NASDAQ:AGEN ) shares in the week since its yearly report...
